Table 3.

Pharmacologics/dietary supplements targeting pain mechanisms tested in mice and/or patients with sickle cell disease

Generic nameMechanistic targetActionSickle subjects
MiceHumans
A-425619 TRPV1 Antagonist  
AT-200 NOP/R and MOR Agonist  
Bosentan ET-A and ET-B receptors Antagonist 
Coenzyme Q10 Oxidative stress Inhibitor 
CP55940 CB1R and CB2R Agonist  
Crizanlizumab P-selectin Antibody  
Cromolyn Mast cell Stabilizer 
Curcumin ROS Inhibitor 
Duloxetine Serotonin and norepinephrine reuptake transporter Inhibitor 
HC-030031 TRPA1 Antagonist  
Imatinib Mast cell/c-kit/RTK Inhibitor 
KN-93 CaMKII Inhibitor  
l-arginine NOS Substrate  
l-glutamine Oxidative stress Antioxidant  
Lovastatin HMG-CoA reductase Inhibitor  
PEG-ADA Adenosine Inhibitor  
Rapamycin mTOR Inhibitor  
HbF Inducer 
Simvastatin HMG-CoA reductase, calpain-1 Inhibitor 
Sivelestat Neutrophil elastase Inhibitor  
TAK-242 TLR4 Inhibitor  
Trifluoperazine CaMKIIα Inhibitor 
ω-3 fatty acid Oxidative stress Antioxidant 
Generic nameMechanistic targetActionSickle subjects
MiceHumans
A-425619 TRPV1 Antagonist  
AT-200 NOP/R and MOR Agonist  
Bosentan ET-A and ET-B receptors Antagonist 
Coenzyme Q10 Oxidative stress Inhibitor 
CP55940 CB1R and CB2R Agonist  
Crizanlizumab P-selectin Antibody  
Cromolyn Mast cell Stabilizer 
Curcumin ROS Inhibitor 
Duloxetine Serotonin and norepinephrine reuptake transporter Inhibitor 
HC-030031 TRPA1 Antagonist  
Imatinib Mast cell/c-kit/RTK Inhibitor 
KN-93 CaMKII Inhibitor  
l-arginine NOS Substrate  
l-glutamine Oxidative stress Antioxidant  
Lovastatin HMG-CoA reductase Inhibitor  
PEG-ADA Adenosine Inhibitor  
Rapamycin mTOR Inhibitor  
HbF Inducer 
Simvastatin HMG-CoA reductase, calpain-1 Inhibitor 
Sivelestat Neutrophil elastase Inhibitor  
TAK-242 TLR4 Inhibitor  
Trifluoperazine CaMKIIα Inhibitor 
ω-3 fatty acid Oxidative stress Antioxidant 

ETA and ETB, endothelin A and endothelin B; CB1R/CB2R, cannabinoid receptor 1/2; HMG-CoA reductase, 3-hydroxy-3-methyl-glutaryl–coenzyme reductase; NE, norepinephrine; NOS, nitric oxide synthase; PEG-ADA, polyethylene glycol–modified adenosine deaminase; TRPA1, transient receptor potential cation channel subfamily A, member 1.

Close Modal

or Create an Account

Close Modal
Close Modal